Brazil’s Iguatemi, Biomm, Blau announce dividends, other highlights

The board of directors of Iguatemi (IGTI11) approved a new share buyback program. The information was released on the evening of Tuesday, June 9. The company and/or its controlled subsidiaries may acquire up to R$60,267,824.90 in IGTI11 units, common shares, and/or preferred shares. Based on the last closing price, this amount corresponds to approximately 2,451,905 IGTI11 units, composed of 2,451,905 common shares and 4,903,810 preferred shares.

According to Iguatemi, the buyback aims to hold the shares in treasury for future cancellation and/or sale, as well as to meet the company’s stock-based compensation plans.

The board of directors of Romi (ROMI3) approved the distribution of interest on equity (JCP) on Tuesday, June 9. This payment will be deducted from the mandatory dividends for the 2026 fiscal year. The gross amount is R$5,590,244.82, which corresponds to R$0.06 per share. The net amount is R$0.051. The cutoff date will be June 15, 2026. As of June 16, 2026, the company’s shares will be traded ex-interest. Payment will occur by December 31, 2027.

Banrisul (BRSR6) announced after the market closed on Tuesday, June 9, that its management board approved the payment of interest on equity for the second quarter of 2026. A total amount of R$90 million will be distributed. The gross unit value per share type and class will be R$0.22006263 per common share, R$0.22006263 per PNA share, and R$0.22006263 per PNB share, subject to income tax according to current legislation. Payment will occur on June 26, 2026, to shareholders registered in the company’s records on June 12, 2026. Shares will be traded ex-right to the intermediate interest starting June 15, 2026.

The board of directors of Totvs (TOTS3), in a meeting held on Tuesday, June 9, approved the payment of interest on equity (JCP) corresponding to R$0.18 per share. The total amount is R$104.3 million. All shareholders holding shares on the base date of June 15, 2026, will be entitled to the JCP. Share trading as of June 16, 2026, will be ex-JCP. Payment to beneficiary shareholders will occur on July 10, 2026, without monetary correction.

Biomm (BIOM3) released its EBITDA guidance for the fiscal year ending December 31, 2026, on Tuesday, June 9. The 2026 EBITDA guidance is between R$90 million and R$100 million. According to the company, the projection was prepared considering the full ramp-up of the Nova Lima plant in Minas Gerais; execution of current PDP contracts, specifically for Glargine (Glargilin) with Biomanguinhos/Fiocruz and human insulin with Funed; expansion of Glargilin in the private market; an average exchange rate for 2026 based on company projections; and the absence of extraordinary events or material adverse regulatory or macroeconomic changes. On May 28, the Biomm board of directors approved the voluntary adoption of the practice of disclosing management financial projections to the market as a tool to improve communication with investors and strengthen the company’s governance practices.

The board of directors of Vittia (VITT3), in a meeting held on Tuesday, June 9, approved the cancellation of 4,455,436 common shares held in treasury, acquired under the 5th share buyback program. Vittia also announced the creation of the 6th common share buyback program. The number of shares to be acquired will be limited to 4,500,000 common shares, representing 2.8% of the company’s total issued shares and 9.4% of the total shares outstanding in the market. The program ends on June 8, 2027.

Fitch Ratings affirmed the Long-Term National Rating of ‘AA+(bra)’ for Blau Farmacêutica (BLAU3) and its sixth unsecured debenture issuance, maturing in 2028, on Tuesday, June 9. The outlook for the corporate rating is stable. According to the agency, Blau’s rating is supported by the solid demand fundamentals of the pharmaceutical industry and its focus on high-complexity, recurrent-use product niches, which mitigates competition risks despite its smaller scale compared to peers. The company also presents operating margins above the industry average and good conversion of EBITDA into operating cash flow. The stable outlook incorporates the expectation of maintaining a conservative capital structure, despite a strong investment plan in the coming years, and recurrent access to funding sources to support operational growth, the agency highlighted in a report.

Metalúrgica Gerdau pays a dividend of R$0.08 per share on Wednesday, June 10. The cutoff date was May 13, 2026. Since May 14, trading of these shares on the stock exchange has been ex-right. Grendene pays a dividend of R$0.22, approved on December 2, 2025, on Wednesday, June 10. It also pays a dividend of R$0.02, approved on May 7, 2026, and a gross amount of R$0.03 in the form of JCP, approved on May 7, 2026. Alupar pays the dividend approved at the annual and extraordinary general meeting held on April 16, 2026, on Wednesday, June 10. The amount is R$9.88 million and corresponds to R$0.01 per common share (ALUP3), R$0.01 per preferred share (ALUP4), and R$0.03 per unit (ALUP11). Shareholders registered as such in the company’s records at the end of April 16, 2026, are entitled to receive these dividends. Since April 17, the shares have been traded ex-dividends.

The recent rise in Brazilian government bond yields has put investors in a wait-and-see mode. With the Tesouro Direto program once again offering real interest rates close to and even above 8% per year, the country’s macroeconomic scenario has become a topic of debate between enthusiasm from those seeking returns and fear from those seeing fiscal deterioration. Charles Mendlowicz, a partner at wealth management consultancy Ticker Wealth and founder of the channel Economista Sincero, said the current movement is a thermometer for Brazil risk, which he believes is already in the red zone. The current rate reflects the market’s perception that the country’s fiscal management has lost predictability. When distrust is high, interest rates remain elevated. According to Mendlowicz, the root of the problem lies in the continuation of a policy focused on increasing current spending at the expense of structural investments. He recalled that promises surrounding the new fiscal framework, which replaced the spending cap under the premise of balancing the accounts, did not hold up in practice. The partner at Ticker Wealth assessed that with rising debt, the cost of rolling over public debt has become a snowball. The government spent R$1 trillion on debt interest in 2025, and indebtedness continues to rise. That money could have been used for schools, universities, hospitals, ports, airports, and highways. Furthermore, Mendlowicz pointed out that the strategy of raising taxes has already reached the limit of the Laffer Curve, resulting in inefficiency and capital flight.